Revascularization of a Chronically Occluded Left Anterior Descending Artery Is it Worth All the Effort?⁎⁎Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Interventions or the American College of Cardiology. by Mehran, Roxana & Dangas, George D.
ER
C
A
I
R
G
N
R
a
s
t
s
c
n
b
i
a
a
p
c
a
s
c
i
a
d
t
a
H
f
w
m
m
i
s
c
t
t
b
c
t
r
r
d
f
r
l
w
u
p
r
o
d
a
a
A
a
r
t
l
s
t
n
c
d
a
C
a
i
o
v
c
a
i
m
t
s
t
L
i
t
a
t
*
a
t
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 1 , N O . 3 , 2 0 0 8
© 2 0 0 8 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 9 8 / 0 8 / $ 3 4 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c i n . 2 0 0 8 . 0 5 . 0 0 2DITORIAL COMMENT
evascularization of a
hronically Occluded Left
nterior Descending Artery
s it Worth All the Effort?*
oxana Mehran, MD, FACC,
eorge D. Dangas, MD, FACC
ew York, New York
evascularization of a chronically occluded coronary
rtery (CTO) has been the focus of investigation from
everal different aspects. Initial studies have reported
echnical tips and tricks, features predicting procedural
uccess, and complications in an effort to decrease the
onsiderably high failure rates. With evolution in tech-
ique, equipment, and expertise, further studies have
een conducted on clinical outcomes and indications,
ncluding the complex area of myocardial viability after
n earlier myocardial infarction in the distribution in the
rea of the occluded coronary artery.
Certain centers, such as the one of the authors of the
aper by Safley et al. (1) in this issue of JACC: Cardiovas-
ular Inteventions, have been practicing CTO procedures in
high-volume center for many years. Indeed, it may be
elf-explanatory to many physicians that opening an oc-
luded coronary artery is supposed to be better than leaving
t closed.
See page 295
The landscape has grown to be more demanding than
nticipated in this field. Generalization of CTO proce-
ures is currently dependent not only on technical exper-
ise but also on establishment of indications widely
ccepted by the emerging centers and new operators.
owever, strategy trials have been very difficult to per-
orm in the ideal, unselected patient population. In other
ords, randomized comparisons of intervention versus
edical therapy for CTO are likely to be conducted
ostly in those patients who are poor candidates for
ntervention (little viability, limited or no symptoms,
Editorials published in JACC: Cardiovascular Interventions reflect the views of the
uthors and do not necessarily represent the views of JACC: Cardiovascular Interven-p
ions or the American College of Cardiology.
From Columbia University Medical Center, New York, New York.mall vessel distribution, diffuse disease, nonoperative
andidate, and so on), while the good candidates are
reated with intervention outside the trial. This is similar
o randomizing only patients who are poor candidates for
oth intervention and surgery for multivessel disease
omparison, while each type of therapy is selected outside
he trial for those who are good candidates! This is the
eality of clinical trials under the pressure of a heavy
egulatory and clinical bias environment.
The investigation by Safley et al. (1) is based on a large
atabase of “all comers” CTO procedures with long-term
ollow-up at a single center with high operator expertise
epresenting their entire experience over the years. The
atter advantage is also one of its limitations: the procedures
ere conducted long ago with a striking 20% rate of stent
se highlighting the technical differences to today’s ap-
roach. We suspect that very few CTO vessels escaped
evascularization attempt by Safley et al. over the many years
f their practice. Although those were not captured in the
atabase, they would likely be an improper medical therapy
rm since they would have very unfavorable angiographic
nd clinical features responsible for their nonselection.
nother group, also not represented in the study of Safley et
l. (1) and potentially closer in characteristics, is the patients
eferred for bypass surgery mainly due to a CTO in one of
he diseased vessels.
The methodology of assessing potential CTO revascu-
arization benefits by comparing the outcomes after
uccessful versus unsuccessful procedures is interesting. If
he vessel is closed to begin with, the procedure should
ot make it any worse. However, the in-hospital compli-
ation rates were higher after unsuccessful CTO proce-
ure, especially in the left anterior descending coronary
rtery (LAD) territory. This implies performance of
TO intervention in high-risk group, perhaps even early
fter myocardial infarction (yet beyond 7 days as clarified
n the study).
The long-term results are in line with other observations
n the importance of the anterior wall for the overall left
entricular performance with implications for patient out-
ome (2–4). Successful CTO procedure in the LAD was
ssociated with improved survival at 5 years. The question
s, how were the CTO failures treated subsequently, with
edical therapy alone or with bypass surgery? We suspect
hat medical therapy is the presumption, and this, indeed,
eems inadequate based on the results reported. The lesson
o be learned from Safley et al. (1) is that a CTO in the
AD needs to have a successful revascularization (especially
n those with evidence of ischemia), and the presumption is
hat surgery would be recommended if an interventional
pproach were unsuccessful.
Is there a clear message regarding medical therapy from
his study? Formally not, but indirectly, yes. When the
otential for improved survival is discussed, many physicians
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304ould feel compelled to recommend revascularization of the
TO in the LAD territory and insist on an ultimately
uccessful strategy.
Revascularization of non-LAD CTOs remains unaf-
ected by this investigation. Indications appear to be
ignificant angina and ischemia, but we do not think
urvival would be jeopardized with an unsuccessful at-
empt. This clinical impression is not altered by the
eport of Safley et al. (1)
We only wished that Safley et al. (1) could have
onducted their CTO procedures under a randomized
rotocol so that their results would provide a model to
ollow, but the previously mentioned limitations on
erforming such trials make this difficult. Great perfor-
ance on a registry-based methodology does not support
ajor conclusions on selecting a therapeutic strategy in
he present day and age. Although difficult, performance
f randomized trials with enthusiastic participation of the
arge patient volume centers and operators is necessary
or definitive conclusions (5).
5eprint requests and correspondence: Dr. Roxana Mehran,
olumbia University Medical Center, 55 East 59th Street, 6th Floor,
ew York, New York 10022-1112. E-mail: rmehran@crf.org
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